Experiences with L-deprenyl in Parkinsonism

Area of Science:

• Neurology
• Pharmacology

Background:

• Parkinson's disease treatment often involves L-Dopa and decarboxylase inhibitors.
• These medications can have significant side effects.
• Exploring adjunctive therapies to improve efficacy and tolerability is crucial.

Purpose of the Study:

• To evaluate the efficacy of deprenyl in combination with standard substitution therapy.
• To assess the impact of deprenyl on motor activity and medication side effects.

Main Methods:

• A study involving 152 patients receiving a combination therapy.
• Assessment of motor activity normalization and side effect profiles.

Main Results:

• A favorable effect on motor activity was observed in approximately two-thirds of patients (152 patients).
• Deprenyl allowed for a reduction in the dosage of L-Dopa and decarboxylase inhibitors.
• This dosage reduction potentially led to a decrease in medication side effects.

Conclusions:

• The combination of deprenyl and substitution therapy shows promise in managing motor symptoms.
• Deprenyl may serve as a valuable adjunct to existing Parkinson's disease treatments.
• A trial of deprenyl is recommended for patients to assess its benefits and tolerability.